Register to use all the features of this website, including selecting clinical areas of interest and “favourite” articles, taking part in quizzes and much more.
Hint: If you are a General Practitioner your username may be your MCNZ#
About us | FAQ | Contact us | Terms of use
Interactive quizzes are based on material found in Best Practice Journal and Best Tests. Initially, quizzes are posted out with journals and GPs are invited to submit their answers for CME credits.
Register or Log in to take part in quizzes.
Login to my bpac.
Don't have an account? Register to use all the features of this website, including selecting clinical areas of interest, taking part in quizzes and much more.
An increasing incidence of early onset type 2 diabetes in New Zealand is putting more people at risk of complications and early... View Article
View Article
Due to its progressive nature, many people with type 2 diabetes will eventually require insulin treatment. In most cases, insulin... View Article
Sodium-glucose co-transporter 2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists have been recommended... View Article
With two new medicines, empagliflozin and dulaglutide, available in New Zealand* for the management of type 2 diabetes, the place... View Article
An annual diabetes review allows for assessment of glycaemic control and earlier detection of, and intervention for, diabetes-related... View Article
The management of type 2 diabetes is multi-faceted, including patient education on management of their condition, lifestyle interventions... View Article
Obesity is contributing to the increasing rate of type 2 diabetes in New Zealand, most notably in people aged under 40 years.... View Article
This report provides an overview of the clinical characteristics of patients with type 2 diabetes* including sex, age, ethnicity... View Article
Living with type 1 diabetes is challenging, particularly as a young adult who is trying to balance the new freedoms of living... View Article
Insulin treatment is an essential component of type 1 diabetes management. Achieving and maintaining good glycaemic control helps... View Article
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease in New Zealand. Preventing or delaying the development... View Article
Type 2 diabetes management in older people can be complex due to the wide variations in co-morbidities, physical and cognitive... View Article
The benefits of intentional weight loss in people who are overweight are obvious and undeniable. However, the vast number of diets,... View Article
A variety of subsidised medicines are available to help manage HbA1c levels in patients with type 2 diabetes, all of which can... View Article
Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor available fully subsidised from 1 October, 2018. DPP-4 inhibitors have... View Article
An increasing incidence of early onset type 2 diabetes in New Zealand is putting more people at risk of early mortality and complications... View Article
The management of type 2 diabetes is multi-faceted. Following diagnosis, patients require education to self-manage their condition... View Article
This report uses data from the pharmaceutical collection and laboratory claims collection to provide an update on diabetes monitoring... View Article
Hyperglycaemia during pregnancy is associated with a range of adverse outcomes which can affect both mother and child, and can... View Article
Diabetic peripheral neuropathy is one of the most common long-term complications of diabetes. It develops in up to half of all... View Article
People with type 2 diabetes and poor glycaemic control (HbA1c > 64 mmol/mol) are at increased risk of developing diabetes-related... View Article
2013 began with publication of the 50th issue of Best Practice Journal. In this edition we focused on the topic at the heart of... View Article
Most people with type 2 diabetes require regular and intensive management to achieve individualised HbA1c targets. Patients should... View Article
Comparing results between different blood glucose meters | Beating the Blues: online cognitive behavioural therapy for mild to... View Article
ON 1 SEPTEMBER 2012, three new diabetes blood glucose meters were listed on the Pharmaceutical Schedule: CareSens II, CareSens... View Article
This report presents how testing for diabetes has changed since the recommendations were published. Patients with diagnosed diabetes... View Article
Until recently, fasting plasma glucose, and in some situations, oral glucose tolerance testing, have been the investigations of... View Article
Intermediate hyperglycaemia is a biochemical state in which a person has glucose levels above the normal range, but does not yet... View Article
A care pathway is a tool that enables practitioners to provide better health care and better patient outcomes at a lower cost.... View Article
This article has been archived. If you would like access to the original article please contact: editor@bpac.org.nz View Article
In the March 2012 issue of Best Tests, bpacnz published an article discussing testing for CVD, diabetes and renal disease in elderly... View Article
ON 1 JULY, 2012 the “Get Checked” programme, under which diabetes follow-up care in New Zealand is funded, will be replaced by... View Article
Consideration of laboratory testing and interpretation of subsequent results should be guided by a patients “drugs, diseases and... View Article
A position statement released by the New Zealand Society for the Study of Diabetes (NZSSD) now recommends the use of glycated... View Article
Due to its progressive nature, many people with type 2 diabetes will eventually require insulin treatment. Insulin initiation... View Article
The PHO Performance Programme was established in 2005 to improve the health of people enrolled in general practices in New Zealand... View Article
The purpose of the PHO Performance Programme is to improve health and reduce disparities among people using primary healthcare... View Article
As of 1 October 2011, laboratories are reporting HbA1c results in millimoles per mole (mmol/mol) only. For the preceding two years,... View Article
Counties Manukau DHB Māori Gout Action Group have identified five publicly held myths about gout and presented a plan with five... View Article
Examines HbA1c and albumin/creatinine ratio testing rates for people with diabetes View Article
Foot ulceration and damage is one of the most common complications of diabetes and without regular screening and effective management,... View Article
Sight-threatening retinopathy is a serious complication of diabetes and is largely preventable through regular retinal screening... View Article
Maintaining good glycaemic control reduces the risk of microvascular complications of type 2 diabetes and may also reduce the... View Article
Humalog, Tramadol and Gabapentin View Article
New Zealanders are getting fatter. That’s a fact. When a problem is getting worse, it is time to reassess the methods we are using... View Article
A short article covering changes in HbA1c test reporting from percentages to molar units (mmol/mol). View Article
There is evidence that early use of insulin in people with type 2 diabetes is beneficial. At present insulin is under used in... View Article
Debate about the clinical usefulness of a diagnosis of metabolic syndrome has been ongoing since it was first described. It is... View Article
Managing diet is a priority for the health and wellbeing of people with diabetes. Measures such as glycaemic index, glycaemic... View Article
New evidence concludes that self monitoring of blood glucose for people with non-insulin treated type 2 diabetes is not beneficial.... View Article
Cardiovascular disease and type II diabetes are major causes of hospitalisations and mortality in Māori. There are many things... View Article
Self-monitoring of blood glucose (SMBG) is an important component of diabetes management for some people. But, which people? SMBG... View Article